United Kingdom· GB-APID-3464411000001101
Disopyramide 100mg capsules
A disopyramide product containing disopyramide, registered in United Kingdom by Viatris UK Healthcare Ltd. The same ATC class is registered in 9 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Disopyramide is registered in 9 of 19 countries.
Countries holding a registration under ATC C01BA03 (disopyramide), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 5 of them publish a price we can compare per daily dose
Disopyramide · ATC C01BA03
9 / 19 countries
- Belgiumprice
- Canada
- Finlandprice
- Franceprice
- Japan
- Netherlands
- Norwayprice
- United Kingdom
- United Statesprice
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Disopyramide
- Manufacturer
- Viatris UK Healthcare Ltd
- Country
- United Kingdom (GB)
- ATC code
- C01BA03
- ATC class
- Disopyramide
- Defined daily dose
- 0.4 g, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin5016695560182
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
341 interactions on record for disopyramide.
Graded by severity as the source publishes them — 138 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Disopyramide · interactions on record
341 records
- 138 severe
- 182 moderate
- 10 minor
- 11 info
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- OndansetronA04AA01severe
- GranisetronA04AA02severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Disopyramide in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesDisopyramide PhosphateTeva Pharmaceuticals USA, Inc.
- SpainDICORYNAN 100 mg CAPSULAS DURASCheplapharm Arzneimittel Gmbh
- BelgiumRythmodan 100 mgCheplapharm Arzneimittel
- FranceRYTHMODAN 100 mg, géluleCHEPLAPHARM ARZNEIMITTEL (ALLEMAGNE)
- FinlandDurbissanofi-Aventis Oy
- CanadaRYTHMODANCHEPLAPHARM ARZNEIMITTEL GMBH
- NorwayRitmodan RetardSanofi
- ItalyRITMODAN RETARD*20 cpr 250 mgCHEPLAPHARM ARZNEIMITTEL GMBH
Authorised across Europe · EMA
The same active substance is authorised in 6 EEA countries. Names it is sold under:
- Belgium · Rythmodan, Rythmodan Long Action
- Spain · Dicorynan
- France · Isorythm L.P., Rythmodan
- Italy · Ritmodan, Ritmodan Retard
- Luxembourg · Rythmodan, Rythmodan Long Action
- Netherlands · Ritmoforine Retard
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fa2fa1d9-073c-4fc5-b2dd-12983eb1edef GET /v1/drugs/fa2fa1d9-073c-4fc5-b2dd-12983eb1edef?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "3464411000001101",
"desc": "Disopyramide 100mg capsules (Viatris UK Healthcare Ltd)",
"form": "Oral capsule",
"vpid": "39690511000001109",
"source": "dmd",
"vtm_id": "773247002",
"strength": "100 mg",
"substance": "Disopyramide",
"ingredient": "Disopyramide",
"supplier_code": "144301000001108"
}See everything about disopyramide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.